The global blood disorders testing market is exhibiting significant increase, propelled by a rising incidence of lymphoma and other related conditions. Analysts estimate the existing market size to be substantial, with projections indicating a steady compound annual growth rate (CAGR) over the coming period. Key trends shaping the industry include